Cartesian Therapeutics, Inc. (RNAC) — Analyst estimates
Consensus analyst estimates for Cartesian Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 275K | -0.97 | 1 |
| 2027 | 82.00K | -0.95 | 1 |
| 2028 | 78.00K | -0.79 | 1 |
| 2029 | 78.00K | -0.77 | 1 |
| 2030 | 23.17M | -0.46 | 1 |
Consensus analyst estimates by fiscal year.